Genetic Testing for Cancer Risk

What is genetic testing for cancer risk?

Cancer genetic testing examines DNA, usually from a blood or saliva sample, to look for inherited gene changes associated with increased cancer risk.

This is different from testing a tumour after cancer has already been diagnosed. Tumour testing looks for genetic changes inside cancer cells that may help doctors understand the cancer or choose treatment. Inherited, or germline, testing looks for changes present throughout the body that may also be passed to children.

Doctar's guide to genetic testing for uterine cancer explains this distinction and discusses genes associated with Lynch syndrome.

The difference matters. A tumour mutation is not automatically an inherited mutation.

Who should consider genetic testing?

Genetic testing is not necessary for everyone. Doctors usually look at the pattern of cancer in a person's family and their own medical history before recommending it.

Testing may be considered when someone has cancer at an unusually young age, several close relatives with related cancers, multiple primary cancers, or a family member already known to carry a cancer-related mutation.

The type of cancer matters, too. A strong family history of breast and ovarian cancer can point toward hereditary breast and ovarian cancer syndromes. A pattern of colorectal and uterine cancers can raise concern about Lynch syndrome.

Doctar's breast cancer guide discusses family history and BRCA1/BRCA2 mutations as factors that can affect breast cancer risk.

Its breast cancer screening guide also explains how family history and known BRCA mutations can affect screening decisions.

BRCA is only one part of genetic risk

BRCA1 and BRCA2 are probably the genes most people have heard about. Harmful inherited variants in these genes can substantially increase the risk of breast and ovarian cancers and are also associated with other cancers.

But a hereditary cancer panel may examine many genes. Depending on the person's history, doctors may consider genes involved in DNA repair, tumour suppression and other biological pathways.

The right test is therefore not necessarily the biggest test. More genes can mean more findings that are difficult to interpret.

Doctar's HRD testing guide for ovarian cancer explains the difference between inherited BRCA testing and tumour-based HRD testing.

For people already diagnosed with breast cancer, Doctar's breast biopsy results guide also notes that genetic testing may be considered as part of further evaluation in appropriate cases.

Lynch syndrome and colorectal cancer

Not all hereditary cancer risk involves BRCA. Lynch syndrome is an inherited condition associated with an increased risk of colorectal and several other cancers.

A family pattern involving colorectal cancer, uterine cancer and certain other cancers can prompt a doctor to consider genetic counselling or testing.

Doctar's colon cancer testing guide discusses Lynch syndrome as a hereditary risk factor that can affect colorectal screening.

Its colonoscopy guide also explains why people with suspected hereditary colorectal cancer syndromes may need a different screening approach from average-risk individuals.

For uterine cancer, Doctar's genetic testing guide describes the role of mismatch-repair genes such as MLH1, MSH2, MSH6 and PMS2.

What happens before the test?

A good genetic evaluation starts with a conversation, not a tube of blood.

A doctor or genetic counsellor may ask about cancers in parents, siblings, children, grandparents, aunts, uncles and cousins. The age at which relatives were diagnosed can be particularly useful.

Try to collect old medical records when possible. Even a simple family cancer history can help the healthcare professional decide whether testing is appropriate and which test makes sense.

In clinical practice, this is often missed because people remember that “someone had cancer” but not what type or at what age. Those details can change the interpretation of hereditary risk.

What do genetic test results mean?

Results are not simply “good” or “bad.” A test may identify a pathogenic variant, meaning a genetic change known to increase disease risk, or it may find a variant whose significance is uncertain.

A negative result can also have different meanings. If a family mutation is already known and the test does not find it, that can be reassuring. But if no specific family mutation has been identified, a negative panel may not completely rule out inherited risk.

This is why genetic counselling matters. The same laboratory result can mean different things depending on the person's family and medical history.

Genetic testing can affect family members

An inherited cancer-risk mutation can be relevant beyond the person who gets tested.

If a clinically significant inherited variant is identified, close relatives may be offered targeted testing and appropriate counselling. This can sometimes change how relatives approach cancer screening and prevention.

The decision should be handled carefully. Genetic information is personal, and people may need time to consider the emotional and family implications before testing.

Doctar's guide to life after cancer and follow-up screening discusses how personal cancer history can influence ongoing monitoring.

Genetic testing after a cancer diagnosis

Genetic testing can also be relevant after cancer has already been diagnosed.

Doctors may use inherited testing to understand whether the cancer could be part of a hereditary syndrome. Separately, tumour genomic testing may identify changes that influence treatment decisions.

For example, Doctar's prostate cancer treatment guide describes tumour genomic profiling for mutations such as BRCA1/2 and ATM in selected prostate cancer patients.

Its prostate cancer guide also discusses inherited genetic factors and family history as part of prostate cancer risk.

Doctar's small-cell prostate cancer article similarly notes that genetic counselling and testing may be considered in people with a strong family history.

Genetic risk can involve several cancer types

Hereditary cancer syndromes do not always stay within one organ.

For example, inherited mutations can be associated with combinations of breast, ovarian, prostate, pancreatic and other cancers. That is why a family history covering several types of cancer can be more informative than looking at one diagnosis in isolation.

Doctar's pancreatic cancer risk guide discusses family history and inherited mutations as potential risk factors.

For lung cancer, Doctar's KRAS mutation guide explains tumour genetic testing and how molecular findings can help classify a cancer.

That is an important distinction: risk testing and tumour testing answer different questions.

What about blood tests for many cancers?

Newer blood-based cancer tests are receiving considerable attention. Some analyse tumour-related signals in the blood and are designed to look for signs of several cancers.

These tests should not be confused with inherited cancer-risk testing.

Doctar's Galleri blood-test explainer discusses multi-cancer early-detection testing and its limitations.

A multi-cancer blood test does not replace established screening or genetic counselling for people with a suspected hereditary cancer syndrome.

Choosing an oncology specialist

If your family history is concerning, an oncologist can help put the information into context. The appropriate specialist may vary according to the cancer pattern and whether you already have a diagnosis.

Doctar lists cancer specialists such as Dr. Somesh Deb in Kolkata, Dr. Rajesh Majumdar Chowdhury, and Dr. Dipanwita Banerjee. Their profiles identify them as oncology specialists, while the exact suitability for genetic counselling or testing should be confirmed directly.

Other Doctar listings include Dr. Basab Bagchi, Dr. Sagar Sen, and Dr. Kakali Choudhury.

In Mumbai, Doctar lists oncology specialists including Dr. Praveen Kammar, Dr. Nikhilesh Borkar, and Dr. Jyoti Poddar. These profiles can help patients explore specialist care by location, but they should not be treated as endorsements or as proof that a particular doctor is appropriate for hereditary cancer testing.

Should you order a genetic test yourself?

Direct-to-consumer testing can sound convenient, but cancer-risk results require medical context. A broad test can uncover findings that are uncertain, difficult to interpret or unrelated to the person's actual cancer risk.

Before paying for a test, ask who will interpret the result, whether genetic counselling is available and whether the laboratory follows appropriate quality standards.

If a test identifies a potentially important mutation, do not make major medical decisions based on the report alone. Take the result to a qualified doctor or genetic professional.